Results 131 to 140 of about 5,114,489 (264)

Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats [PDF]

open access: yes, 2011
BACKGROUND: This work aimed at determining whether bisphosphonate therapy produces a sufficient condition for jaw osteonecrosis after tooth extraction. METHODS: Rats were allocated into 3 groups: (1) 11 rats treated with alendronate, (2) 10 rats treated ...
Azambuja, Alan Arrieira   +4 more
core   +1 more source

Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, 2019
Purpose The purpose of this study was to determine the efficacy and tolerability of different antiresorptive therapeutic regimens for treating symptomatic bone marrow lesions (BML) of the knee.
F. Müller, K. Appelt, C. Meier, N. Suhm
semanticscholar   +1 more source

Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial [PDF]

open access: gold, 2022
Qi Liu   +9 more
openalex   +1 more source

Adjuvant Zoledronic Acid in High‐Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial

open access: yesThe Oncologist, 2019
Lessons Learned. Adjuvant treatment with zoledronic acid did not decrease the recurrence rate of giant cell tumor of bone (GCTB) in this study. The efficacy could not be determined because of the small sample size. GCTB recurrences, even in the denosumab
A. Lipplaa   +6 more
semanticscholar   +1 more source

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures

open access: yesOrthopaedic Surgery, 2019
To observe the effect of zoledronic acid on the reduction of acute bone loss and fracture rate in elderly postoperative patients with intertrochanteric fracture.
Zhong Liu   +6 more
semanticscholar   +1 more source

Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

open access: yesHealth Technology Assessment, 2013
Background: Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.
J Ford   +10 more
doaj   +1 more source

Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma [PDF]

open access: diamond, 2014
Iris C. Salaroglio   +6 more
openalex   +1 more source

Zoledrinic Acid Induces Steoblastic Differentiation of Mesenchymal Stem Cells without Change in Hypomethylation Status of OSTERIX Promoter [PDF]

open access: yesCell Journal, 2012
Objective: Mechanism of zoledronic acid on osteoblastic differentiation of mesenchymal stem cells (MSCs) has not fully understood. With the knowledge of some drugs mechanism that alter methylation pattern of some genes, the present research sets out to ...
Maryam Mahmodinia Maymand   +5 more
doaj  

Home - About - Disclaimer - Privacy